ArticlePloS one2020

Alpha-1 blocker use increased risk of subsequent renal cell carcinoma: A nationwide population-based study in Taiwan.

Shian-Ying Sung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.